Xtant Medical CEO resigns
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Dan Goldberger resigned as CEO and director of Xtant Medical Holdings Inc. and its units on Jan. 21 to pursue other interests.
Current President Carl O'Connell will serve as interim CEO while the company's board contemplates a permanent replacement for Goldberger.
